Schedule 13G ownership disclosure
CIDARA THERAPEUTICS INC
Security class unavailable · CUSIP: 171757107
Event date: 2018-12-21
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-18-003393
- Form type
- SC 13G
- Filer
- BIOTECHNOLOGY VALUE FUND L P
- CIK
- CIK 918923
- Filed
- Dec 28, 2018
- Reporting period
- Dec 21, 2018
- Description
- Schedule 13G beneficial ownership